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Abstract
Background
MPT64 rapid speciation tests are increasingly being used in diagnosis of tuberculosis (TB).
Mycobacterium africanumWest Africa 2 (Maf 2) remains an important cause of TB in West
Africa and causes one third of disease in The Gambia. Since the introduction of MPT64 anti-
gen tests, a higher than expected rate of suspected non-tuberculous mycobacteria (NTM)
was seen among AFB smear positive TB suspects, which led us to prospectively assess
sensitivity of the MPT64 antigen test in our setting.
Methodology/Principal Findings
We compared the abundance of mRNA encoded by thempt64 gene in sputa of patients
with untreated pulmonary TB caused byMaf 2 andMycobacterium tuberculosis (Mtb). Sub-
sequently, prospectively collected sputum samples from presumptive TB patients were
inoculated in the BACTECMGIT 960 System. One hundred and seventy-three acid fast
bacilli (AFB)-positive and blood agar negative MGIT cultures were included in the study.
Cultures were tested on the day of MGIT positivity with the BD MGIT TBc Identification Test.
A random set of positives and all negatives were additionally tested with the SD Bioline Ag
MPT64 Rapid. MPT64 negative cultures were further incubated at 37°C and retested until
positive. Bacteria were spoligotyped and assigned to different lineages.Maf 2 isolates were
2.52-fold less likely to produce a positive test result and sensitivity ranged from 78.4% to
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84.3% at the beginning and end of the recommended 10 day testing window, respectively.
There was no significant difference between the tests. We further showed that the
decreased rapid test sensitivity was attributable to variations in mycobacterial growth
behavior and the smear grades of the patient.
Conclusions/Significance
In areas whereMaf 2 is endemic MPT64 tests should be cautiously used and MPT64 nega-
tive results confirmed by a second technique, such as nucleic acid amplification tests, to
avoid their misclassification as NTMs.
Author Summary
Diagnostics for rapid confirmation of positive liquid cultures presumptive ofMycobacte-
rium tuberculosis bacteria, based on the detection of the MPT64 antigen, are being used in
many TB diagnostic laboratories worldwide. Of note, diagnostic performance of these tests
in West Africa, where TB is uniquely caused by the geographically restrictedMycobacte-
rium africanum (Maf 1 and 2) andMycobacterium tuberculosis lineages, has not been
properly assessed. AlthoughM. tuberculosis andM. africanum are genetically related, they
differ in various aspects. Amongst several differences,Maf 2 grows significantly slower
thanMtb bacteria. Because secretion of the MTP64 protein is dependent on the bacterial
growth rate, we found that the MPT64 rapid test performance for detectingMaf 2 was
lower in our setting in The Gambia. These findings might be relevant for other West Afri-
canMaf 2 endemic countries where this rapid test is commonly used, asMaf 2 infected
patients might have been missed in the past. Our finding emphasizes the need to thor-
oughly consider the presence of bacterial variants specific to certain regions during prod-
uct development and implementation of novel diagnostic tests.
Introduction
Tuberculosis remains a significant public health problem in Africa. Key to interrupting trans-
mission, which is an essential step to reduce the incidence of TB, is timely identification and
treatment of diseased individuals. This objective has fueled research into new generations of
diagnostics and drugs. MPT64 is a 24kD secreted protein that has been explored in diagnostics
and vaccine design due to several properties: it has been associated with virulence, is highly
immunogenic and is produced solely by members of theMycobacterium tuberculosis complex
[1,2,3]. MPT64 is the target of three widely used rapid speciation lateral flow assays for the
identification of the MTBc in culture; BDMGIT TBc Identification Test (BD TBc ID) (Becton
Dickinson Diagnostics, Becton, Dickinson and Company, Sparks, Maryland, USA), SD Bioline
Ag MPT64 Rapid (SD Bioline) (Standard diagnostics, Inc., Yongin-si, Gyeonggi-do, Republic
of Korea), and Capilia TB-Neo (TAUNS Laboratories, Inc., Numazu, Shizuoka, Japan). Despite
the advantage of a lateral flow assay, there have been reports of the failure of MPT64 tests to
detect MTBc isolates, resulting in erroneous reporting of Non-tuberculous mycobacteria
(NTM) isolation [2,3,4,5]. Inability to identify the MTBc will lead to delays in initiating appro-
priate treatment with dire consequences for the patient and their communities given the con-
tinued risk of TB transmission.
TB Rapid Test Performance in The Gambia, West Africa
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The global phylogeographical distribution of the MTBc suggests that strain diversity is
greatest in West Africa, with a representation of all major MTBc lineages [6]. Differences
between these MTBc lineages might affect the performance of diagnostics and vaccines [7].
Thus, West Africa is ideal for providing a global snapshot of the performance of TB diagnostics
and vaccines. Interestingly, few studies assessing commercially available MPT64 MTBc rapid
speciation tests were undertaken within African populations. They were mostly done in Asia,
America and Europe where strain diversity is significantly lower [8].
Lineage 6,Mycobacterium africanum (Maf) West African 2, is geographically restricted to
West Africa, causing up to one third of clinically reported TB. We and others have previously
described inherent genotypic and phenotypic differences betweenMycobacterium tuberculosis
sensu stricto (Mtb) andMaf 2 strains in vitro and within the host [9,10,11,12]. Since we previ-
ously observed differences in various virulence factors betweenMaf 2 andMtb and MPT64 is a
described virulence factor, we hypothesized that the sensitivity of MPT64 rapid tests for MTBc
identification could be different forMaf 2 relative toMtb strains.
In The Gambia, whereMaf 2 is commonly isolated, we compared the abundance of mRNA
encoded by thempt64 gene inMaf 2 strains versusMtb strains in the sputa of untreated TB
patients. Thempt64 (Rv1980c) mRNA transcript was significantly less abundant in the sputa
of TB patients infected withMaf 2 compared withMtb. Therefore we concluded thatMaf 2
might either produce the MPT64 protein at a slower rate and possibly below the limit of detec-
tion of the rapid tests. We confirmed this hypothesis and found a reducedMaf 2 sensitivity of
rapid tests. Further, we compared the time to detection of the MPT64 antigen by the BD TBc
ID and SD Bioline rapid tests between clinical isolates ofMtb andMaf 2. We report lineage
dependent and time specific differences in conversion to MPT64 test positivity. Our findings
have direct implications on the performance of these and other MPT64 based tools in West
Africa.
Materials and Methods
Ethics Statement
This study was nested within an intervention trial of Enhanced Case Finding in The Gambia
(Clinicaltrials.gov NCT01660646). The parent study, including bacterial sub-studies, received
ethical approval from the Joint Gambia Government/MRC Ethics Committee and the Institute
of Tropical Medicine (ITM), Antwerp Institutional Review Board. Written informed consent
was obtained from all participants who were assigned unique identifiers for purposes of ano-
nymity and confidentiality.
Microscopy and Decontamination of Sputum
Sputum samples were prospectively collected from individuals with suspected TB between
April and October 2014 and were all initially screened for the presence of AFB by Auramine
microscopy. Fresh samples were decontaminated by the NALC-NaOHmethod as described
previously [13]. The purity of all decontaminated samples was subsequently checked on blood
agar for 48 hours at 37°C and screened for AFB by Ziehl-Neelsen [14] staining, during which
time the decontaminated sputa were stored at -20°C, prior to inoculation.
MtbGene Expression Analysis in Sputum
Sputa from 11 adult patients with smear positive TB that had not started therapy were collected
and stored in Guanidine Isothiocyanate. Later 5Maf 2 and 6Mtb sputum specimens were re-
suspended in Trizol for total RNA isolation. Gene expression ofmpt64 gene was performed
TB Rapid Test Performance in The Gambia, West Africa
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using Multiplex qPCR with previously published TaqMan primer-probe sets as described pre-
viously [15,16]. Multiplex RT-PCR data were normalized and analysed according to a previ-
ously published method. For a detailed description please refer to Garcia et al. [17].
Bacterial Culture
Confirmed blood agar negative and AFB positive samples were cultured within the BACTEC
MGIT 960 System (MGIT 960; Becton Dickinson Microbiology Systems, Sparks, Maryland,
USA) at 37°C according to the manufactures’ instructions. Instrument positive vials were
removed from the machine and again subjected to purity check using blood agar and ZN
microscopy to confirm the presence of AFB. Cultures with growth on blood agar and/or AFB
negative were excluded from the study.
MPT64 Antigen Test
Blood agar negative and AFB positive MGIT cultures were tested on the day of MGIT positivity
(day 0, T0) with the BD TBc ID rapid speciation lateral flow assay, following the manufacturers’
instructions. The BD TBc ID manual specifies that tests should be performed on AFB-positive
MGIT tubes only if AFB-positive organisms predominate on a smear and cautions on the pos-
sibility of false results due to the presence of non-AFB organisms in cultures. In order to test
whether the lower sensitivity of the MPT64 assay was specific to one manufacturer, we addi-
tionally tested all BD TBc ID negative samples at T0, including a random number of positive
samples, with the SD Bioline kit at the same time points. Tests were always independently eval-
uated by at least two blinded readers; in case of discordance between the readers a third blinded
reader was consulted. Faint bands were considered as positive results. Results were recorded
after 15 minutes and negative cultures at T0 were retested at 3, 10, 15 and 90 days with both the
BD TBc ID and SD Bioline rapid speciation kits.
Spoligotyping
Aliquots of the MGIT cultures were taken at T0 and heat killed. These lysates were genotyped
by spoligotyping as previously described [18]. Patient isolates were assigned to specific TB line-
ages using the TB-lineage tool [19] within the TB-Insight public database.
Statistical Analysis
We plotted the survival curves forMaf 2 andMtb conversion to rapid test positivity at 1, 3, 10,
15 and 90 days and used the generalized Log-rank test for interval-censored failure time [20] to
compare the two survivor functions. We estimated the effect of MTBc lineage (Maf 2 andMtb)
on the time-to-conversion to rapid test positivity using a Weibull regression model for inter-
val-censored failure time [20] after controlling for testing time interval, age, gender, smear
grade, duration spent in the MGIT, mycobacterial growth units, and whether patients had
already initiated therapy. The BD TBc ID manual indicated that tests could be performed
within 10 days after MGIT tube positivity, while SD Bioline did not specify any time interval
for the performance of tests. Therefore, for comparative evaluation we stratified both analyses
by a 0–10 days testing window and 10–90 days follow-up. A paired interval-censored analysis
was used to compare BD TBc ID and SD Bioline performance. All analyses were performed
using STATA 13.1 (Stata Corp., College Station, Texas).
TB Rapid Test Performance in The Gambia, West Africa
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Results
Lower Expression of thempt64 Transcript in the Sputa ofM. africanum
Compared toM. tuberculosis TB Patients
On comparing the abundance of themtp64mRNA transcript in sputum samples from 6
Mtb and 5Maf 2 infected patients, who had not received any TB treatment, the mpt64 tran-
script was significantly less abundant in the sputa ofMaf 2-infected patients, compared to
sputa ofMtb-infected patients (fold change = 2.52, p = 0.006). To validate our expression
data, we measured the abundance of mRNA transcripts of the gene (Rv2355) responsible for
the transposition of IS6110 elements inMaf 2 samples sinceMaf 2 is known to have lower
copy numbers of IS6110 elements thanMtb [21]. Interestingly, we found a significantly
reduced abundance of mRNA transcripts of this transposase in Maf 2 samples. In vitro
under expression of the polyketide synthesis loci responsible for production of sulfolipids in
Maf 2 has been reported [22], which were also significantly downregulated inMaf 2 in our ex
vivo data. For a detailed overview of mRNA expression for each individual patient please see
S3 Table.
Culture of Bacteria
Altogether, 193 sputum samples from 193 presumptive TB patients were cultured in the MGIT
960 System. For a summary of patients’ characteristics see Table 1. Of the 193 cultures, 20
(10.4%) were excluded from the study due to missing patient data (n = 4; (2.1%)), being AFB
negative and contaminated with other microorganisms on blood agar (n = 4; (2.1%)), AFB neg-
ative without contamination (n = 9; (4.7%)), or AFB positive and contaminated (n = 3; (1.5%))
(see Fig 1).
A hundred and seventy-three positive cultures (89.6%), from 168 AFB smear positive and 5
AFB smear negative sputa, were blood agar negative, AFB positive by ZN staining and were
tested with the BD TBc ID kit (Fig 1). One hundred and fifty samples tested positive with the
BD TBc ID speciation kit on T0, with 23 testing negative at this time point, representing 13.2%
of cultures tested.
Table 1. Clinical and demographic characteristics of study participants.
Maf 2 Mtb
(n = 51) (n = 122)
Age, median (range) 30 (17–67) 30 (15–90)
Gender
Male, n (%) 46 (90.2) 79 (64.8)
Female, n (%) 5 (9.8) 43 (35.2)
Smear grade, n (%)
Scanty 4 (7.8) 15 (12.3)
+ 14 (27.5) 28 (23.0)
++ 11 (21.6) 37 (30.3)
+++ 22 (43.1) 42 (34.4)
Therapy, n (%)
Yes 24 (47.1) 60 (49.2)
No 10 (19.6) 18 (14.8)
Unknown 17 (33.3) 44 (36.1)
doi:10.1371/journal.pntd.0004801.t001
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Lower Sensitivity of MPT64 Tests forM. africanum thanM. tuberculosis
All 173 samples were spoligotyped and assigned to a lineage within the MTBc. Samples geno-
typed belonged to lineages 1 (Indo-oceanic), 2 (East-Asian/Beijing), 4 (Euro-American) or 6
(Maf 2).
The conversion time of the BD TBc ID assay did not differ among the threeMtb lineages-
East-Asian, Euro-American and Indo-Oceanic (East-Asian and Euro-American (p = 0.55),
East-Asian and Indo-Oceanic (p = 0.89) and Euro-American and Indo-Oceanic (p = 0.63) (S1
Table). Therefore, we combined the three lineages into one group,Mtb.
We found an overall reduced rapid test sensitivity forMaf 2 when compared toMtb (see Fig
2 and Table 2).
There was strong evidence of a difference in the time to detection betweenMaf 2 andMtb
(P = 0.001), withMtb strains having a higher rate of conversion to BD TBc ID rapid test posi-
tivity thanMaf 2 (Fig 2 and Table 2).
After controlling for age, gender, smear grade, duration spent in the MGIT automated cul-
ture system, mycobacterial growth units, and whether patients had already received some TB
therapy, in a multivariable analysis, there was strong evidence of association between species
Fig 1. Flowchart describing sample collection and processing.
doi:10.1371/journal.pntd.0004801.g001
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and conversion to BD TBc ID positivity during the first 10 days (p<0.0001, Table 3). The rate
of rapid test positivity inMtb-infected patients was almost 4 times higher compared toMaf 2-
infected patients within the first 10 days. From 10–90 days, there was no evidence of difference
in the time to a positive test betweenMtb andMaf 2 (p = 0.15, Table 3).
There was strong evidence of association between smear grade and conversion to positivity
(p = 0.0001, Table 3) after controlling for lineage, testing time interval, gender, age, therapy,
duration spent in the MGIT and mycobacterial growth units. The rate of conversion to positiv-
ity in patients having smear grade +++ was about 3 times higher than patients with a scanty
smear. Generally, cultures that spent longer in the MGIT automated culture system before
turning culture positive were more likely to have a BD TBc ID positive rapid test result at T0
(p<0.0001).
As shown in Table 3, there were no associations between conversion to BD TBc ID positivity
and gender, age, therapy or mycobacterial growth units.
As only a subset of MGIT cultures were tested with both MPT64 assays, firstly, we assessed if
there was any evidence of selection bias. Finding none (S2 Table), we compared their performance
Fig 2. Kaplan-Meier survival plot showing the difference in conversion to rapid test positivity forMtb
strains andMaf 2. The Log-rank test was used to compare the survivor functions ofMtb andMaf 2. The gray
shaded area indicates the sampling time window recommended by the manufacturer.
doi:10.1371/journal.pntd.0004801.g002
Table 2. Percentage of samples converting to positivity over time using BD TBc ID.
% of positive samples (95% CI) p#
Maf 2 Mtb
(n = 51) (n = 122)
BD TBc ID
Day 0 (T0) 78.4 (65.4–87.5) 90.2 (83.6–94.3) 0.04
Day 3 (T3) 80.4 (67.5–89.0) 95.1 (89.7–97.7) 0.002
Day 10 (T10) 84.3 (72.0–91.8) 97.5 (93.0–99.2) 0.001
Day 15 (T15) 90.2 (79.0–95.7) 97.5 (93.0–99.2) 0.04
Day 90 (T90) 98.0 (89.7–99.7) 98.4 (94.2–99.5) 0.88
# Two-sample test for proportions.
doi:10.1371/journal.pntd.0004801.t002
TB Rapid Test Performance in The Gambia, West Africa
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004801 July 7, 2016 7 / 12
in a paired interval-censored analysis restricted to samples with results from both assays, correct-
ing for the same explanatory variables as used in the BD TBc ID survival analysis.
Within each time interval and for each strain, there was no evidence of difference in time to
rapid test positivity between BD TBc ID and SD Bioline (Table 4), suggesting that the decreased
sensitivity may not be manufacturer specific yet intrinsic to the MPT64 target.
Discussion
Our findings suggest 2.5-fold decreased expression of thempt64 gene in Lineage 6 ofM. africa-
num compared toM. tuberculosis and a significant decrease in sensitivity (78% on day T0) of
the MPT64 based lateral flow assays for speciation of Lineage 6 cultures relative toM. tubercu-
losis, as members of the MTBc.
Among the smear microscopy positive TB suspects enrolled in the present study, all were
ultimately confirmed as MTBc infected, although 22% ofMaf 2 patients, and 10% of MTB
patients, would have been misclassified as NTMs if the tests had not been repeated after T0, the
day the MGIT culture turned positive. During the 10-day MGIT positive window recom-
mended by the BD TBc ID manufacturer, only 84% of allMaf 2 were detected by a positive test
versus 98% ofMtb strains. Given the relatively low cost, limited technical expertise and shorter
turnaround time associated with using rapid speciation tests compared to alternative speciation
methods, MPT64 rapid tests will likely remain one of the preferred options for timely diagnosis
of suspected TB despite the possibility of false negative results. Therefore, a negative MPT64
result would require confirmation by an alternative method, such as molecular tests or culture
on para-nitrobenzoic acid (PNB), depending on laboratory infrastructure and resources. As
BD and SD Bioline MPT64 rapid tests have been on the market for over a decade now, several
groups have now evaluated them. The inability of the MPT64 tests to detect strains that have
Table 3. Multivariable analysis of BD TBc ID conversion time to positivity using interval-censored fail-
ure time regression usingWeibull distribution. Each individual regression was adjusted for all other
variables.
Adjusted HR t (95% CI) p
Testing time interval
0–10 days Maf 2 1 -
Mtb 3.47 (1.75–6.88) <0.0001
10–90 days Maf 2 1 -
Mtb 0.33(0.08–1.48) 0.15
Gender Female 1 -
Male 0.83 (0.49–1.40) 0.49
Age 0.99 (0.97–1.01) 0.13
Smear grade 0.01a
Scanty 1 -
+ 1.31 (0.64–2.68) 0.47
++ 1.29 (0.63–2.63) 0.49
+++ 2.91 (1.38–6.14) 0.005
Therapy No 1 -
Yes 0.95 (0.62–1.46) 0.82
Time to MGIT positivity (h) 1.004 (1.002–1.004) <0.0001
MGIT Growth units 1.00 (0.99–1.01) 0.33
a Wald test assessing evidence of overall association between smear grade and time-to-conversion.
doi:10.1371/journal.pntd.0004801.t003
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lost thempt64 gene or acquired mutations has been reported previously [4,23]. A recent meta-
analysis reported a sensitivity 95% yet studies evaluating these tests were conducted using a
very limited panel of MTBc lineages, the majority belonging toM. tuberculosis sensu stricto
lineages.
Two studies includingMaf were biased by the low number of isolates evaluated compared
toMtb strains tested [24,25]. In their analysis of the sensitivity of the BD TBc ID test using ref-
erence strains, Yu et al included oneMaf strain among 24 NTM strains, 18 mixtures ofM.
tuberculosis and NTM strains, 2M. bovis strains and 1 Nocardia spp. strain. In the same study,
171 clinical respiratory specimen were prospectively analyzed yet these were allM. tuberculosis
isolates [25]. Gaillard and co-workers, in their assessment of both the SD Bioline and BD TBc
ID tests, included 20Maf among 318 MTBc consisting of 242M. tuberculosis, 53M. canettii, 2
M. bovis and 1M. bovis BCG Pasteur [24]. Although allMaf strains were detected, neither of
the studies specified whetherMaf 1 orMaf 2 isolates were tested. Interestingly, an earlier report
hinted on the possibility of MPT64 rapid test sensitivity being influenced by the amount of
antigen secreted by the metabolically growing MTBc cells and emphasised the need to deter-
mine factors driving secretion [26]. Notably, Gaillard and co-workers reported the production
of a faint band after the standard 15 min incubation period by 8 out of 20Maf strains tested
during their evaluation of both the SD Bioline and BD TBc ID tests. They suggested further
incubation of cultures which produce faint bands to allow production of greater amounts of
antigen by the MTBc strain that could be clearly detected as positive [24]. Interestingly, in this
study, we also observed an association between the duration spent by cultures in the MGIT
automated culture system and positive rapid test results. The longer cultures spent in the
MGIT culture system, the more likely they were to produce detectable amounts of MPT64 and
therefore a positive rapid test result. Furthermore, Gagneux and colleagues detected a non-syn-
onymous SNP in thempt64 gene of all isolates fromMaf 1, which they hypothesized could
affect the sensitivity of MPT64 tests in West Africa [7]. As noMaf 1 was identified in our
study, the sensitivity of the MPT64 rapid tests to detectMaf 1 will need to be validated
Table 4. Paired interval-censored survival analysis of conversion to positivity between BD TBc ID and
SD.
HR adjusted for testing time point (95% CI)* p
Conversion to rapid test positivity in Maf
0–10 days
TBc 1
SD 0.60 (0.35–1.01) 0.06
10–90 days
TBc 1
SD 0.86 (0.47–1.56) 0.62
Conversion to rapid test positivity in Mtb
0–10 days
TBc 1
SD 1.39 (0.72–2.68) 0.33
10–90 days
TBc 1
SD 1.39 (0.72–2.68) 0.33
*: All estimates were adjusted for gender, age, therapy, smear grade, time to MGIT positivity and MGIT
Growth units.
doi:10.1371/journal.pntd.0004801.t004
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elsewhere. However, in a report from Nigeria, no failures of the MPT64 test were reported in
detectingMaf 1, albeit not all positive cultures were accounted for [27].
One possible explanation for the evidence of association between high smear grade and
rapid test positivity could be the presence of a greater number of actively dividing cells secret-
ing the MPT64 antigen leading to an abundance of antigen in the growth medium. Interest-
ingly,Mtb strains reportedly divide significantly faster thanMaf 2 strains [9]. Since the
secretion of MPT64 has previously been linked to active cell division [1] the differential growth
behaviour could also support our finding of lower detection of MPT64 rapid tests forMaf 2.
Additionally future studies should ascertain if the observed under expression ofmpt64 inMaf
2 was due to mutations in the gene. Whole genome sequencing will also enable us to confirm if
theseMaf 2 strains belong to a unique clone that is currently spreading in the Gambia or
whether it is a general trait ofMaf 2.
Conclusions
Our findings indicate that MPT64 tests need to be cautiously used in settings whereMaf 2 is
common. Different modifications of workflow can be considered, such as repeating the MPT64
assay after 10 days on all T0 MPT64 negative cultures, and molecular confirmation as MTBc vs
NTMs in AFB positive cultures that test MPT64 negative. A preferred approach will be to
apply the Xpert MTB/RIF assay or Line-Probe-Assays (LPA) to all AFB positive, MPT64 nega-
tive cultures. Generally, our findings strongly emphasize the need to consider strain diversity
during TB product development. Our study further demonstrates that a careful evaluation and
validation of novel tests before implementation, especially in regions with geographically
restricted MTBC lineages, such asM. africanum in West Africa, is imperative.
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